<?xml version="1.0" encoding="UTF-8"?>
<results title="drug">
 <result pre="1994; Lalezari et al., 2003), and a small-molecule CCR5 antagonist," exact="maraviroc" post="(Fatkenheuer et al., 2005), must act on the cell"/>
 <result pre="in clinics, including (1) M2 ion channel inhibitors, such as" exact="amantadine" post="(Bright et al., 2006) and rimantadine, which block viral"/>
 <result pre="FDA-approved drugs with anti-ZIKV activities have been identified, such as" exact="Sofosbuvir" post="(Xu et al., 2016), but no drug has been"/>
 <result pre="of HSV infection, including (1) the nucleoside analogs such as" exact="acyclovir" post="(ACV), (2) the acyclic nucleotide analog cidofovir and (3)"/>
 <result pre="analogs such as acyclovir (ACV), (2) the acyclic nucleotide analog" exact="cidofovir" post="and (3) the pyrophosphate analog foscarnet (Kimberlin and Whitley,"/>
 <result pre="immunological response, and vaccine development.J. Immunol. Res.2019:649173810.1155/2019/6491738 NgK. E. (2019)." exact="Xofluza" post="(Baloxavir Marboxil) for the treatment of acute uncomplicated influenza.P"/>
 <result pre="fusion inhibitor.Clin. Immunol.11526â€&quot;32. 10.1016/j.clim.2005.02.01915870017 PhillipsD. M.TaylorC. L.ZacharopoulosV. R.MaguireR. A. (2000)." exact="Nonoxynol-9" post="causes rapid exfoliation of sheets of rectal epithelium.Contraception62149â€&quot;154. 10.1016/s0010-7824(00)00156-611124363"/>
</results>
